Stocks
Milestone Pharmaceuticals Inc.MIST
NASDAQHealthcareBiotechnology$1.70-2.86%
Clinical-stage biotechnology company developing therapies for cardiovascular conditions, with a focus on rapid, self-administered treatments for acute arrhythmias. Its lead candidate, etripamil, is a nasal spray being studied for the treatment of paroxysmal supraventricular tachycardia (PSVT) and ot...
Market Cap: $144.8M52W Range: $0.63 – $3.06
Congressional Interest in Milestone Pharmaceuticals Inc. (MIST)
No congressional trades have been disclosed for Milestone Pharmaceuticals Inc. (MIST) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading MIST?
No congressional trades found for this stock.